Venture Capital Blog

For entrepreneurs seeking venture capital, understanding pre-money valuation and post-money valuation is essential for successful fundraising. These valuation concepts help determine the equity exchanged for investment and shape long-term outcomes. 

Buy-and-build is an effective business growth strategy that involves acquiring and integrating smaller, complementary companies into a larger platform. The strategy is often adopted by private equity firms and expanding businesses that aim to scale operations rapidly, enhance market presence, and drive value. 

Balderton Capital, a leading European venture capital firm, has announced the successful raise of $1.3 billion to support tech startups across Europe. 

Indiana's tech venture capital (VC) scene is experiencing a remarkable surge, outpacing national trends even as the broader US market faces challenges. 

Business intelligence (BI) tools and private equity firms utilize information in the finance sector to create reliable investment decisions. The finance sector deals with huge amounts of information, often regarded as a goldmine of data to shape strategy and inform key decisions. 

In high-stakes venture capital, the allure of unearthing the next disruptive technology is akin to a modern-day gold rush. But as with any treasure hunt, the path is fraught with risk and uncertainty. How do discerning investors differentiate genuine disruptors from mere flashes in the pan? How can they navigate the labyrinth of hype and buzzwords to pinpoint technologies poised to reshape industries?

Aperture Finance, a leading DeFi (decentralized finance) industry player, is expanding its reach. With a recent funding boost of $12 million, the company is poised to revolutionize the DeFi landscape with its groundbreaking AI-powered Intents infrastructure. 

The impact of venture capital on healthcare innovation is clear. VC-backed companies have pioneered healthcare innovations in the past decade and are revolutionizing healthcare with new cancer and rare disease treatments, medical device innovations, and digital health.

Progentos Therapeutics announced that it has successfully raised $65 million in a Series A funding round. Progentos is a Boston-based startup with the mission of developing groundbreaking treatments for diseases that affect nerve cells, such as Multiple Sclerosis (MS) and other demyelinating diseases.

According to KPMG's new Venture Pulse report, global Venture Capital (VC) investment plummeted to $75.9 billion across 7,520 deals in Q1 of 2024. This decline is attributed to geopolitical tensions, a lack of market exits, and a discernible reduction in investment during the later deal stages. This article will analyze key trends from Q1 2024 data and provide actionable insights for VCs navigating the evolving landscape.